GramEye Inc.

About GramEye Inc.

GramEye aims to create a world where antibacterial drugs are appropriately prescribed in medical settings worldwide, addressing the natural phenomenon of drug-resistant bacteria caused by the use of antimicrobials.

Products & Services

Automated AI device for Gram staining: A product developed to automate microbial testing (Gram staining) in medical institutions.

Specialties

Microbial testing automation AI in medical devices Gram staining technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series B T: - FT: Series B	A: 570000000 MR: - FA: 570 million yen FAN: 570000000	D: 2025-11-21 FD: 2025-11-21	3 investors

Series B Latest

2025-11-21

$570.0M

3 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

A

Alexander Fleming

Doctor

平

平岡悠

Representative Director / Osaka University Graduate School of Medicine / Physician

山

山田達也

Director / Osaka University Graduate School of Medicine / Physician

中

中島真平

Director / Head of Business Development Department

松

松蔭瞭

CTO / AI Engineer / Software Engineer

桐

桐谷健太

Research and Development

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

GramEye Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised